Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Two Phase 1 studies have been conducted with AEG33773 and available safety and tolerability
data from these studies support further clinical development of AEG33773. The current study
is proposed as a proof-of-concept study to assess the potential analgesic efficacy of
AEG33773 to reduce pain associated with chronic Diabetic Peripheral Neuropathy.